<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ911122-0110</DOCNO><DOCID>911122-0110.</DOCID><HL>   Business Brief -- Pharmaceutical Resources Inc.:   Par Unit and Government   Reach Settlement of Probe</HL><DATE>11/22/91</DATE><SO>WALL STREET JOURNAL (J), NO PAGE CITATION</SO><CO>   PRX</CO><MS>CONSUMER NON-CYCLICAL (NCY)</MS><IN>DRUG MANUFACTURERS (DRG)</IN><GV>JUSTICE DEPARTMENT (JUS)</GV><RE>MARYLAND (MD)NORTH AMERICA (NME)NEW YORK (NY)UNITED STATES (US)</RE><LP>   Pharmaceutical Resources Inc., Spring Valley, N.Y., saidits Par Pharmaceutical unit entered into an agreement withthe U.S. government to settle a two-year federalinvestigation of the generic drug company.   Par agreed with the Justice Department and the U.S.attorney in Maryland to plead guilty to 10 drug and other lawviolations, and pay a $2.5 million fine.</LP><TEXT>   Par is one of several generic drug companies that havebeen investigated in recent years; Par was charged withfiling false drug applications with the Food and DrugAdministration, submitting false samples, distributingadulterated generic drug products, and other violations.   Par in 1990 was convicted of paying unlawful gratuities toFDA employees and was fined $150,000.   Kenneth I. Sawyer, president and chief executive officerof Pharmaceutical Resources, said the company has replacedall management employees with any involvement in illegalactivities, and &quot;made the changes necessary to see that suchbehavior will not recur.&quot;   He said the settlement frees the company to &quot;resolving allremaining matters and to rebuilding our tablet and capsulebusiness.&quot;</TEXT></DOC>